Insider Transactions in Q4 2025 at Harmony Biosciences Holdings, Inc. (HRMY)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 12
2025
|
Jeffrey M. Dayno PRESIDENT, CEO |
SELL
Open market or private sale
|
Direct |
25,933
-100.0%
|
$1,037,320
$40.11 P/Share
|
|
Dec 12
2025
|
Jeffrey M. Dayno PRESIDENT, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+50.0%
|
$160,000
$8.22 P/Share
|
|
Dec 05
2025
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
20,000
-100.0%
|
$780,000
$39.54 P/Share
|
|
Dec 05
2025
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+50.0%
|
$580,000
$29.03 P/Share
|
|
Nov 21
2025
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,427
-100.0%
|
$119,945
$35.0 P/Share
|